Bortezomib induces apoptosis via the JNK/p38 MAPK pathway in esophageal squamous cell carcinoma, multiple myeloma cells, and glioblastoma cells [22,36,37]. The gene discussed is MAPK8; the disease is esophageal squamous cell carcinoma.